GlassScriptPhysician profile
Nadia Hameed
NPI 1710145636
$2,452.92
in general payments reported to CMS, 2019-2025
19 companies · $39.70 in 2025
The $39.70 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $426 · 2021: $278 · 2022: $827 · 2023: $152 · 2024: $460 · 2025: $39.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $860.92 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $343.34 | 2019-2024 | Mounjaro |
| Medtronic, INC. | $262.15 | 2021-2024 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.72 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $184.04 | 2021-2023 | |
| Xeris Pharmaceuticals, INC. | $146.38 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Horizon Therapeutics Plc | $124.96 | 2022 | |
| Amgen INC. | $54.83 | 2019-2021 | |
| Bigfoot Biomedical INC | $26.18 | 2022 | |
| Radius Health, INC. | $24.99 | 2024 | Tymlos |
| Dexcom, INC. | $24.92 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $24.62 | 2020 | |
| Mannkind Corporation | $22.77 | 2022 | |
| Zealand Pharma US, INC. | $21.23 | 2021 | |
| Pfizer INC. | $20.73 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Companion Medical, INC. | $20.69 | 2020 | |
| Abbvie INC. | $18.68 | 2021 | |
| Sequel Med Tech, LLC | $17.63 | 2025 | Twiist |
| Lifescan, INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Hameed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.